German biotech company developing non-viral CAR-T cell therapies and platform technologies (including ex-vivo clinical programs and proprietary non-viral, potentially in-vivo CAR-T generation) to make CAR-T therapies more economical, scalable and accessible.
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| €20 M | Dec, 2025 | series-a |
Industries
Frequently Asked Questions
What industries does T-CURX GmbH operate in?
T-CURX GmbH operates in the following industries: biotech, healthcare, cell therapy, immunotherapy.
When was T-CURX GmbH founded?
T-CURX GmbH was founded on 2025-12-18.
How much total funding has T-CURX GmbH raised?
T-CURX GmbH has raised a total of $20,000,000.
Who are the investors in T-CURX GmbH?
The investors in T-CURX GmbH are: BiomedVC, HighLight Capital (HLC), i&iBio Fund, Existing and new private investors.